ILCC 2022 Conference Coverage

 

ILCC 2022 Conference Coverage
T

Neoadjuvant vs. Adjuvant Immunotherapy From the Surgeon's Perspective

By ILCC 2022 Conference Coverage FEATURING Tetsuya Mitsudomi
By ILCC 2022 Conference Coverage FEATURING Tetsuya Mitsudomi
0 views
August 29, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

06:27
Johnson & Johnson

Challenges to Navigate in Locally Advanced or Metastatic EGFR+ NSCLC

Feat. M. Socinski, D. Waterhouse

Featured Video

08:44
Johnson & Johnson

Management and Proactive Care of Adverse Events Associated with Loca…

Feat. J. Sabari, A. Spira
Videos
18:14
ILCC 2022 Conference Coverage

Systemic Therapy for Brain Metastases in NSCLC

Feat. E. Massarelli
17:29
ILCC 2022 Conference Coverage

Neoadjuvant vs. Adjuvant Immunotherapy From the Surgeon's Persp…

Feat. T. Mitsudomi
09:57
ILCC 2022 Conference Coverage

ILCC 2022 Mesothelioma: Updates in Systemic Therapy

Feat. P. Baas
01:21
ILCC 2022 Conference Coverage

Lecture Summary - 1L Single Agent Immunotherapy for mNSCLC

Feat. A. Chiang
14:33
ILCC 2022 Conference Coverage

1L Single Agent Immunotherapy for mNSCLC

Feat. A. Chiang
09:30
ILCC 2022 Conference Coverage

ILCC 2022 on The Role of PARP Inhibitors in DNA Damage Response in L…

Feat. P. Bunn